Immunohistochemical expression of human epidermal growth factor receptor (HER)-4 and prognosis in patients with metastatic breast cancer

---

Atıf İçin Kopyala

DELİGÖNÜL A., EVRENSEL T., Avci N., UĞRAŞ N., Ture M., ÇUBUKÇU E., ...Daha Fazla

JOURNAL OF BUON, cilt.21, sa.3, ss.564-569, 2016 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 21 Sayı: 3
• Basım Tarihi: 2016
• Dergi Adı: JOURNAL OF BUON
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.564-569
• Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Purpose: The clinical value of HER4 - a cell surface receptor that belongs to the human epidermal growth factor receptor family - for predicting survival outcomes in patients with breast cancer remains controversial. Herein, we sought to investigate the prognostic significance of HER4 immunohistochemical expression with respect to progression-free survival (PFS) and overall survival (OS) in Turkish patients with metastatic breast cancer (MBC).